Polyunsaturated fatty acids and their metabolites in brain function and disease

The brain is highly enriched with fatty acids. These include the polyunsaturated fatty acids (PUFAs) arachidonic acid and docosahexaenoic acid, which are largely esterified to the phospholipid cell membrane. Once PUFAs are released from the membrane, they can participate in signal transduction, either directly or after enzymatic conversion to a variety of bioactive derivatives ('mediators'). PUFAs and their mediators regulate several processes within the brain, such as neurotransmission, cell survival and neuroinflammation, and thereby mood and cognition. PUFA levels and the signalling pathways that they regulate are altered in various neurological disorders, including Alzheimer's disease and major depression. Diet and drugs targeting PUFAs may lead to novel therapeutic approaches for the prevention and treatment of brain disorders.

[1]  R. Godbout,et al.  Fatty acid binding proteins in brain development and disease. , 2010, The International journal of developmental biology.

[2]  F. Calon,et al.  Accumulation of Dietary Docosahexaenoic Acid in the Brain Attenuates Acute Immune Response and Development of Postischemic Neuronal Damage , 2011, Stroke.

[3]  N. Dolu,et al.  Maternal intake of Omega-3 essential fatty acids improves long term potentiation in the dentate gyrus and Morris water maze performance in rats , 2012, Brain Research.

[4]  M. Vohl,et al.  Plasma n-3 fatty acid response to an n-3 fatty acid supplement is modulated by apoE ɛ4 but not by the common PPAR-α L162V polymorphism in men , 2009, British Journal of Nutrition.

[5]  its Panel on Folate,et al.  Evidence from Animal Studies on the Etiology of Neural Tube Defects , 1998 .

[6]  S. Rapoport,et al.  Recent studies on interactions between n-3 and n-6 polyunsaturated fatty acids in brain and other tissues , 2002, Current opinion in lipidology.

[7]  Charles N. Serhan,et al.  Pro-resolving lipid mediators are leads for resolution physiology , 2014, Nature.

[8]  Lars-Olof Wahlund,et al.  Omega-3 fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study: a randomized double-blind trial. , 2006, Archives of neurology.

[9]  N. Stella.  Endocannabinoid signaling in microglial cells , 2009, Neuropharmacology.

[10]  A. Nadjar,et al.  n-3 LCPUFA improves cognition: the young, the old and the sick. , 2014, Prostaglandins, leukotrienes, and essential fatty acids.

[11]  Hsin-Chieh Yeh,et al.  Effect of the 2011 vs 2003 duty hour regulation-compliant models on sleep duration, trainee education, and continuity of patient care among internal medicine house staff: a randomized trial. , 2013, JAMA internal medicine.

[12]  M. Feki,et al.  Polyunsaturated fatty acids deficits are associated with psychotic state and negative symptoms in patients with schizophrenia. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[13]  P. Watkins.  Fatty acid activation. , 1997, Progress in lipid research.

[14]  G. Young,et al.  Blood phospholipid fatty acid analysis of adults with and without attention deficit/hyperactivity disorder , 2004, Lipids.

[15]  Song‐Pyo Hong,et al.  Novel Docosanoids Inhibit Brain Ischemia-Reperfusion-mediated Leukocyte Infiltration and Pro-inflammatory Gene Expression* , 2003, Journal of Biological Chemistry.

[16]  R. Holman,et al.  A case of human linolenic acid deficiency involving neurological abnormalities. , 1982, The American journal of clinical nutrition.

[17]  J. Axelrod,et al.  Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. , 1990, Biochemical Society transactions.

[18]  P. Barberger‐Gateau,et al.  Adherence to a Mediterranean diet and plasma fatty acids: data from the Bordeaux sample of the Three-City study , 2011, British Journal of Nutrition.

[19]  E. Nelson,et al.  The Relationship of Docosahexaenoic Acid (DHA) with Learning and Behavior in Healthy Children: A Review , 2013, Nutrients.

[20]  M. Lynch,et al.  Apoptotic Changes in the Aged Brain Are Triggered by Interleukin-1β-induced Activation of p38 and Reversed by Treatment with Eicosapentaenoic Acid* , 2002, The Journal of Biological Chemistry.

[21]  Shih-Yi Huang,et al.  A Meta-Analytic Review of Polyunsaturated Fatty Acid Compositions in Patients with Depression , 2010, Biological Psychiatry.

[22]  X. Zhang,et al.  Increased Phospholipase A2 Activity and Inflammatory Response But Decreased Nerve Growth Factor Expression in the Olfactory Bulbectomized Rat Model of Depression: Effects of Chronic Ethyl-Eicosapentaenoate Treatment , 2009, The Journal of Neuroscience.

[23]  B. Davletov,et al.  Regulation of SNARE fusion machinery by fatty acids , 2007, Cellular and Molecular Life Sciences.

[24]  K. Hashimoto,et al.  Fabp7 Maps to a Quantitative Trait Locus for a Schizophrenia Endophenotype , 2007, PLoS biology.

[25]  A. Obenaus,et al.  Novel aspirin-triggered neuroprotectin D1 attenuates cerebral ischemic injury after experimental stroke , 2012, Experimental Neurology.

[26]  P. Tso,et al.  Selective Deficits in the Omega-3 Fatty Acid Docosahexaenoic Acid in the Postmortem Orbitofrontal Cortex of Patients with Major Depressive Disorder , 2007, Biological Psychiatry.

[27]  P. Tso,et al.  Deficits in docosahexaenoic acid and associated elevations in the metabolism of arachidonic acid and saturated fatty acids in the postmortem orbitofrontal cortex of patients with bipolar disorder , 2008, Psychiatry Research.

[28]  R. Eckel,et al.  Regulation of fatty acid uptake into tissues: lipoprotein lipase- and CD36-mediated pathways Published, JLR Papers in Press, November 24, 2008. , 2009, Journal of Lipid Research.

[29]  S. Rapoport,et al.  Imaging brain signal transduction and metabolism via arachidonic and docosahexaenoic acid in animals and humans , 2012, Brain Research Bulletin.

[30]  N. Salem,et al.  An n-3 fatty acid deficient diet affects mouse spatial learning in the Barnes circular maze. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[31]  S. Rapoport,et al.  Brain lipid concentrations in bipolar disorder. , 2010, Journal of psychiatric research.

[32]  J. Schaffer,et al.  As a matter of fat. , 2009, Cell metabolism.

[33]  S. Dahlén,et al.  Leukotrienes and lipoxins: structures, biosynthesis, and biological effects. , 1987, Science.

[34]  N. Bazan,et al.  Membrane docosahexaenoate is supplied to the developing brain and retina by the liver. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[35]  Xiao Hong Ma,et al.  Bioequivalence of Dietary α-Linolenic and Docosahexaenoic Acids as Sources of Docosahexaenoate Accretion in Brain and Associated Organs of Neonatal Baboons , 1999, Pediatric Research.

[36]  R. Bazinet,et al.  A minimum of 3 months of dietary fish oil supplementation is required to raise amygdaloid afterdischarge seizure thresholds in rats - implications for treating complex partial seizures , 2013, Epilepsy & Behavior.

[37]  D. Speijer.  Oxygen radicals shaping evolution: Why fatty acid catabolism leads to peroxisomes while neurons do without it , 2011, BioEssays : news and reviews in molecular, cellular and developmental biology.

[38]  R. Palmiter,et al.  Leptin-regulated endocannabinoids are involved in maintaining food intake , 2001, Nature.

[39]  Takashi Morihara,et al.  Dietary n‐3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease , 2005, The European journal of neuroscience.

[40]  S. Rapoport,et al.  Energy Consumption by Phospholipid Metabolism in Mammalian Brain , 2002, Neurochemical Research.

[41]  J. Hamilton,et al.  A Model for Fatty Acid Transport into the Brain , 2007, Journal of Molecular Neuroscience.

[42]  H. Amièva,et al.  Omega-3 fatty acids and cognitive decline: modulation by ApoEε4 allele and depression , 2011, Neurobiology of Aging.

[43]  N. Salem,et al.  Omega-3 fatty acids and rodent behavior. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[44]  Takashi Morihara,et al.  A Diet Enriched with the Omega-3 Fatty Acid Docosahexaenoic Acid Reduces Amyloid Burden in an Aged Alzheimer Mouse Model , 2005, The Journal of Neuroscience.

[45]  D. Maiguel,et al.  The Fatty Acid Transport Protein (FATP) Family: Very Long Chain Acyl-CoA Synthetases or Solute Carriers? , 2007, Journal of Molecular Neuroscience.

[46]  C. Pariante,et al.  Phospholipase A2 and Cyclooxygenase 2 Genes Influence the Risk of Interferon-α–Induced Depression by Regulating Polyunsaturated Fatty Acids Levels , 2010, Biological Psychiatry.

[47]  V. King,et al.  Omega-3 Fatty Acids Improve Recovery, whereas Omega-6 Fatty Acids Worsen Outcome, after Spinal Cord Injury in the Adult Rat , 2006, The Journal of Neuroscience.

[48]  J. Axelrod,et al.  A transduction pathway associated with receptors coupled to the inhibitory guanine nucleotide binding protein Gi that amplifies ATP-mediated arachidonic acid release. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[49]  J. Rapoport,et al.  The Utility of 11C-Arachidonate PET to Study in vivo Dopaminergic Neurotransmission in Humans , 2012, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[50]  P. Rogers,et al.  Updated systematic review and meta-analysis of the effects of n-3 long-chain polyunsaturated fatty acids on depressed mood. , 2010, The American journal of clinical nutrition.

[51]  P. Pencharz,et al.  A comparison of the metabolism of eighteen-carbon 13C-unsaturated fatty acids in healthy women Published, JLR Papers in Press, December 16, 2003. DOI 10.1194/jlr.M300304-JLR200 , 2004, Journal of Lipid Research.

[52]  Frank M LaFerla,et al.  Dietary Docosahexaenoic Acid and Docosapentaenoic Acid Ameliorate Amyloid-β and Tau Pathology via a Mechanism Involving Presenilin 1 Levels , 2007, The Journal of Neuroscience.

[53]  Steven A. Connor,et al.  DHA supplementation enhances high-frequency, stimulation-induced synaptic transmission in mouse hippocampus. , 2012, Applied physiology, nutrition, and metabolism = Physiologie appliquee, nutrition et metabolisme.

[54]  S. Rapoport,et al.  Altered arachidonic acid cascade enzymes in postmortem brain from bipolar disorder patients , 2011, Molecular Psychiatry.

[55]  S. Vannucci,et al.  Substrates of Energy Metabolism of the Pituitary and Pineal Glands , 1983, Journal of neurochemistry.

[56]  R. Schneiter,et al.  Lipid signalling in disease , 2008, Nature Reviews Molecular Cell Biology.

[57]  S. Cunnane,et al.  Breast-fed infants achieve a higher rate of brain and whole body docosahexaenoate accumulation than formula-fed infants not consuming dietary docosahexaenoate , 2000, Lipids.

[58]  S. Rapoport,et al.  One generation of n-3 polyunsaturated fatty acid deprivation increases depression and aggression test scores in rats Published, JLR Papers in Press, October 6, 2005. , 2006, Journal of Lipid Research.

[59]  M. Lagarde,et al.  DHA Metabolism: Targeting the Brain and Lipoxygenation , 2010, Molecular Neurobiology.

[60]  A. Truswell,et al.  Cholesterol and beyond , 2010 .

[61]  M. Lavialle,et al.  DHA enhances the noradrenaline release by SH-SY5Y cells , 2010, Neurochemistry International.

[62]  F. Bosetti.  Arachidonic acid metabolism in brain physiology and pathology: lessons from genetically altered mouse models , 2007, Journal of neurochemistry.

[63]  E. Nelson,et al.  An assessment of dietary docosahexaenoic acid requirements for brain accretion and turnover during early childhood. , 2009, World review of nutrition and dietetics.

[64]  S. Shaikh,et al.  N-3 fatty acids and membrane microdomains: from model membranes to lymphocyte function. , 2012, Prostaglandins, leukotrienes, and essential fatty acids.

[65]  P. Subbaiah,et al.  Regioisomers of Phosphatidylcholine Containing DHA and Their Potential to Deliver DHA to the Brain: Role of Phospholipase Specificities , 2013, Lipids.

[66]  J. Bockaert,et al.  NMDA receptors activate the arachidonic acid cascade system in striatal neurons , 1988, Nature.

[67]  M. Lagarde,et al.  Brain-targeting form of docosahexaenoic acid for experimental stroke treatment: MRI evaluation and anti-oxidant impact. , 2011, Current neurovascular research.

[68]  K. Gawrisch,et al.  The structure of DHA in phospholipid membranes , 2003, Lipids.

[69]  R. Malenka,et al.  Postsynaptic TRPV1 triggers cell type–specific long-term depression in the nucleus accumbens , 2010, Nature Neuroscience.

[70]  S. Mongrand,et al.  Docosahexaenoic acid prevents lipopolysaccharide‐induced cytokine production in microglial cells by inhibiting lipopolysaccharide receptor presentation but not its membrane subdomain localization , 2008, Journal of neurochemistry.

[71]  W. Lefkowitz,et al.  Where Does the Developing Brain Obtain Its Docosahexaenoic Acid? Relative Contributions of Dietary α-Linolenic Acid, Docosahexaenoic Acid, and Body Stores in the Developing Rat , 2005, Pediatric Research.

[72]  G. Cole,et al.  What was lost in translation in the DHA trial is whom you should intend to treat , 2011, Alzheimer's Research & Therapy.

[73]  M. Bloch,et al.  Omega-3 Fatty Acids for the Treatment of Depression: Systematic Review and Meta-Analysis , 2011, Molecular Psychiatry.

[74]  D. Guilloteau,et al.  Serotoninergic neurotransmission is affected by n‐3 polyunsaturated fatty acids in the rat , 2004, Journal of neurochemistry.

[75]  S. Rapoport,et al.  Brain metabolism of nutritionally essential polyunsaturated fatty acids depends on both the diet and the liver. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[76]  V. King,et al.  A combination of intravenous and dietary docosahexaenoic acid significantly improves outcome after spinal cord injury. , 2007, Brain : a journal of neurology.

[77]  N. Bazan,et al.  Inflammatory, Apoptotic, and Survival Gene Signaling in Alzheimer’s Disease , 2010, Molecular Neurobiology.

[78]  Hee-Yong Kim,et al.  Effect of Docosahexaenoic Acid on the Synthesis of Phosphatidylserine in Rat Brain Microsomes and C6 Glioma Cells , 1998, Journal of neurochemistry.

[79]  P. Montgomery,et al.  Low Blood Long Chain Omega-3 Fatty Acids in UK Children Are Associated with Poor Cognitive Performance and Behavior: A Cross-Sectional Analysis from the DOLAB Study , 2013, PloS one.

[80]  K. Hamazaki,et al.  Abnormalities in the fatty acid composition of the postmortem entorhinal cortex of patients with schizophrenia, bipolar disorder, and major depressive disorder , 2013, Psychiatry Research.

[81]  C. DeCarli,et al.  Red blood cell omega-3 fatty acid levels and markers of accelerated brain aging , 2012, Neurology.

[82]  D. Piomelli,et al.  Peripheral gating of pain signals by endogenous lipid mediators , 2014, Nature Neuroscience.

[83]  Abdulmajeed Al Abdukareem.  Randomized, placebo-controlled trial , 2004, Annals of Saudi medicine.

[84]  K. Weylandt,et al.  Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway[S] , 2014, Journal of Lipid Research.

[85]  B. Leonard,et al.  Ethyl-eicosapentaenoic acid ingestion prevents corticosterone-mediated memory impairment induced by central administration of interleukin-1β in rats , 2004, Molecular Psychiatry.

[86]  P. Barberger‐Gateau,et al.  Docosahexaenoic acid homeostasis, brain aging and Alzheimer's disease: Can we reconcile the evidence? , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[87]  F. Calon,et al.  Docosahexaenoic Acid-Derived Neuroprotectin D1 Induces Neuronal Survival via Secretase- and PPARγ-Mediated Mechanisms in Alzheimer's Disease Models , 2011, PloS one.

[88]  Hee-Yong Kim,et al.  Inhibition of Neuronal Apoptosis by Docosahexaenoic Acid (22:6n-3) , 2000, The Journal of Biological Chemistry.

[89]  J. Bell,et al.  Half‐lives of docosahexaenoic acid in rat brain phospholipids are prolonged by 15 weeks of nutritional deprivation of n‐3 polyunsaturated fatty acids , 2004, Journal of neurochemistry.

[90]  S. Rapoport,et al.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients. , 2013, Journal of psychiatric research.

[91]  Amanda J. Anderson,et al.  Improving the neurodevelopmental outcomes of low-birthweight infants. , 2013, Nestle Nutrition Institute workshop series.

[92]  P. Watkins,et al.  Comparative Biochemical Studies of the Murine Fatty Acid Transport Proteins (FATP) Expressed in Yeast* , 2005, Journal of Biological Chemistry.

[93]  J. Crystal,et al.  An endocannabinoid mechanism for stress-induced analgesia , 2005, Nature.

[94]  F. Schmidt.  Meta-Analysis , 2008 .

[95]  A. Schene,et al.  Relationship between the hypothalamic–pituitary–adrenal-axis and fatty acid metabolism in recurrent depression , 2013, Psychoneuroendocrinology.

[96]  U. Ramakrishnan,et al.  Role of docosahexaenoic acid in maternal and child mental health. , 2009, The American journal of clinical nutrition.

[97]  A. Nadjar,et al.  Named Series : Diet , Inflammation and the Brain Nutritional n-3 PUFAs deficiency during perinatal periods alters brain innate immune system and neuronal plasticity-associated genes , 2014 .

[98]  S. Rapoport,et al.  Dietary n‐6 polyunsaturated fatty acid deprivation increases docosahexaenoic acid metabolism in rat brain , 2012, Journal of neurochemistry.

[99]  T. Hamazaki,et al.  n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[100]  Takashi Morihara,et al.  Docosahexaenoic Acid Protects from Dendritic Pathology in an Alzheimer's Disease Mouse Model , 2004, Neuron.

[101]  O Matzinger,et al.  Fish oil prevents the adrenal activation elicited by mental stress in healthy men. , 2003, Diabetes & metabolism.

[102]  P. Nathanielsz,et al.  Brain Docosahexaenoate Accretion in Fetal Baboons: Bioequivalence of Dietary α-Linolenic and Docosahexaenoic Acids , 1997, Pediatric Research.

[103]  M. Dougados,et al.  A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial , 2010, Annals of the rheumatic diseases.

[104]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[105]  An Historical Perspective (Une Perspective Historique) , 1994 .

[106]  J. Miranda,et al.  Docosahexaenoic acid pretreatment confers protection and functional improvements after acute spinal cord injury in adult rats. , 2012, Journal of neurotrauma.

[107]  W. Olson,et al.  Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials. , 2006, Bipolar disorders.

[108]  C. Serhan,et al.  Novel Docosatrienes and 17S-Resolvins Generated from Docosahexaenoic Acid in Murine Brain, Human Blood, and Glial Cells , 2003, The Journal of Biological Chemistry.

[109]  A. Nadjar,et al.  Short-Term Long Chain Omega3 Diet Protects from Neuroinflammatory Processes and Memory Impairment in Aged Mice , 2012, PloS one.

[110]  A. Cantor,et al.  The relationship between age and the fatty acid composition of cerebral cortex and erythrocytes in human subjects , 2001, Brain Research Bulletin.

[111]  L. Lauritzen,et al.  Maternal fatty acid status during pregnancy and lactation and relation to newborn and infant status. , 2011, Maternal & child nutrition.

[112]  P. Castillo,et al.  Endocannabinoid Signaling and Synaptic Function , 2012, Neuron.

[113]  J. Bryan,et al.  Influences of micronutrient and omega-3 fatty acid supplementation on cognition, learning, and behavior: methodological considerations and implications for children and adolescents in developed societies. , 2012, Nutrition reviews.

[114]  R. Bazinet,et al.  Brain phospholipid arachidonic acid half-lives are not altered following 15 weeks of N-3 polyunsaturated fatty acid adequate or deprived diet , 2010, Journal of Lipid Research.

[115]  W. Gordon,et al.  Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. , 2011, Annual review of nutrition.

[116]  Cécile Proust-Lima,et al.  Plasma long-chain omega-3 fatty acids and atrophy of the medial temporal lobe , 2012, Neurology.

[117]  S. Innis.  Dietary omega 3 fatty acids and the developing brain , 2008, Brain Research.

[118]  Hee-Yong Kim,et al.  Mechanisms of action of docosahexaenoic acid in the nervous system , 2001, Lipids.

[119]  B. Watkins,et al.  Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. , 2011, The Journal of nutritional biochemistry.

[120]  L. Horrocks,et al.  Modulation of inflammation in brain: a matter of fat , 2006, Journal of neurochemistry.

[121]  B. Davletov,et al.  Omega-3 and omega-6 fatty acids stimulate cell membrane expansion by acting on syntaxin 3 , 2006, Nature.

[122]  S. Layé.  Polyunsaturated fatty acids, neuroinflammation and well being. , 2010, Prostaglandins, leukotrienes, and essential fatty acids.

[123]  S. Tufik,et al.  Chronic ω-3 fatty acids supplementation promotes beneficial effects on anxiety, cognitive and depressive-like behaviors in rats subjected to a restraint stress protocol , 2011, Behavioural Brain Research.

[124]  S. Rapoport.  Translational studies on regulation of brain docosahexaenoic acid (DHA) metabolism in vivo. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[125]  S. Rapoport,et al.  Mode of action of mood stabilizers: is the arachidonic acid cascade a common target? , 2008, Molecular Psychiatry.

[126]  R. Dantzer,et al.  Uncoupling of interleukin‐6 from its signalling pathway by dietary n‐3‐polyunsaturated fatty acid deprivation alters sickness behaviour in mice , 2008, The European journal of neuroscience.

[127]  S. Fukuhara,et al.  Systematic review and metaanalysis: urinary antigen tests for Legionellosis. , 2009, Chest.

[128]  G. Zunta-Soares,et al.  Celecoxib as an adjunct in the treatment of depressive or mixed episodes of bipolar disorder: a double‐blind, randomized, placebo‐controlled study , 2008, Human psychopharmacology.

[129]  R. Coleman,et al.  Cellular fatty acid uptake: the contribution of metabolism , 2006, Current opinion in lipidology.

[130]  E. Hjorth,et al.  Immunomodulation of microglia by docosahexaenoic acid and eicosapentaenoic acid , 2012, Current opinion in clinical nutrition and metabolic care.

[131]  M. Lynch,et al.  Modulation of amyloid‐β‐induced and age‐associated changes in rat hippocampus by eicosapentaenoic acid , 2007, Journal of neurochemistry.

[132]  Yogesh K. Dwivedi,et al.  Lower docosahexaenoic acid concentrations in the postmortem prefrontal cortex of adult depressed suicide victims compared with controls without cardiovascular disease. , 2013, Journal of psychiatric research.

[133]  G. D. Paolo,et al.  Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Cancer.

[134]  E. Baudouin,et al.  A matter of fat , 2011, Plant signaling & behavior.

[135]  P. Barberger‐Gateau,et al.  Plasma eicosapentaenoic acid is inversely associated with severity of depressive symptomatology in the elderly: data from the Bordeaux sample of the Three-City Study. , 2008, The American journal of clinical nutrition.

[136]  G. Hatch,et al.  Fatty acid transport into the brain: of fatty acid fables and lipid tails. , 2011, Prostaglandins, leukotrienes, and essential fatty acids.

[137]  Sarah A. Chau,et al.  Effects of omega-3 fatty acids on cognitive performance: a meta-analysis , 2012, Neurobiology of Aging.

[138]  F. Cicchetti,et al.  Impact of omega-3 fatty acids in Parkinson's disease , 2011, Ageing Research Reviews.

[139]  A. Mackinnon,et al.  Long-Chain -3 Fatty Acids for Indicated Prevention of Psychotic Disorders A Randomized, Placebo-Controlled Trial , 2010 .

[140]  S. Chalon.  Omega-3 fatty acids and monoamine neurotransmission. , 2006, Prostaglandins, leukotrienes, and essential fatty acids.

[141]  F. Pifferi,et al.  n-3 Fatty acids modulate brain glucose transport in endothelial cells of the blood-brain barrier. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[142]  S. Aid,et al.  Journal of Neuroinflammation Neuroinflammatory Response to Lipopolysaccharide Is Exacerbated in Mice Genetically Deficient in Cyclooxygenase-2 , 2008 .

[143]  R. Coleman,et al.  Long-chain acyl-CoA synthetases and fatty acid channeling. , 2007, Future lipidology.

[144]  F. Gomez-Pinilla,et al.  Dietary omega-3 fatty acids normalize BDNF levels, reduce oxidative damage, and counteract learning disability after traumatic brain injury in rats. , 2004, Journal of neurotrauma.

[145]  D. Piomelli,et al.  Dopamine D2 Receptors Potentiate Arachidonate Release via Activation of Cytosolic, Arachidonate‐Specific Phospholipase A2 , 1995, Journal of neurochemistry.

[146]  Michael Weiner,et al.  Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial. , 2010, JAMA.

[147]  T. Bisogno,et al.  Anandamide and diet: Inclusion of dietary arachidonate and docosahexaenoate leads to increased brain levels of the corresponding N-acylethanolamines in piglets , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[148]  A. Nadjar,et al.  Transgenic Increase in n-3/n-6 Fatty Acid Ratio Protects Against Cognitive Deficits Induced by an Immune Challenge through Decrease of Neuroinflammation , 2015, Neuropsychopharmacology.

[149]  F. Bosetti,et al.  Cyclooxygenase‐1 and ‐2 enzymes differentially regulate the brain upstream NF‐κB pathway and downstream enzymes involved in prostaglandin biosynthesis , 2006, Journal of neurochemistry.

[150]  J. Mann,et al.  Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. , 2011, The Journal of clinical psychiatry.

[151]  S. Innis,et al.  Dietary polyunsaturated fat that is low in (n-3) and high in (n-6) fatty acids alters the SNARE protein complex and nitrosylation in rat hippocampus. , 2007, The Journal of nutrition.

[152]  L. H. Kuller,et al.  Benefits of fatty fish on dementia risk are stronger for those without APOE ε4 , 2005, Neurology.

[153]  R. Bazinet,et al.  β-oxidation and rapid metabolism, but not uptake regulate brain eicosapentaenoic acid levels. , 2015, Prostaglandins, leukotrienes, and essential fatty acids.

[154]  Charles N Serhan,et al.  A role for docosahexaenoic acid-derived neuroprotectin D1 in neural cell survival and Alzheimer disease. , 2005, The Journal of clinical investigation.

[155]  S. Layé,et al.  Long term adequate n-3 polyunsaturated fatty acid diet protects from depressive-like behavior but not from working memory disruption and brain cytokine expression in aged mice , 2012, Brain, Behavior, and Immunity.

[156]  S. Innis,et al.  Docosahexaenoic and arachidonic acid prevent a decrease in dopaminergic and serotoninergic neurotransmitters in frontal cortex caused by a linoleic and alpha-linolenic acid deficient diet in formula-fed piglets. , 1999, The Journal of nutrition.

[157]  P. Tso,et al.  Elevated delta-6 desaturase (FADS2) expression in the postmortem prefrontal cortex of schizophrenic patients: Relationship with fatty acid composition , 2009, Schizophrenia Research.

[158]  R. Bazinet,et al.  Increases in seizure latencies induced by subcutaneous docosahexaenoic acid are lost at higher doses , 2012, Epilepsy Research.

[159]  L. Lannfelt,et al.  Serum fatty-acid composition and the risk of Alzheimer’s disease: a longitudinal population-based study , 2012, European Journal of Clinical Nutrition.

[160]  S. Layé,et al.  Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion , 2014, Translational Psychiatry.

[161]  J. Palmblad,et al.  - 3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease : OmegAD Study A Randomized Double-blind Trial , 2006 .

[162]  M. F. Luxwolda,et al.  Fetal intrauterine whole body linoleic, arachidonic and docosahexaenoic acid contents and accretion rates. , 2012, Prostaglandins, leukotrienes, and essential fatty acids.

[163]  F. Calderon,et al.  Docosahexaenoic acid promotes neurite growth in hippocampal neurons , 2004, Journal of neurochemistry.

[164]  Mathieu Géraldine,et al.  DHA enhances the noradrenaline release by SH-SY5Y cells , 2010, Neurochemistry International.

[165]  A. Mackinnon,et al.  Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. , 2010, Archives of general psychiatry.

[166]  M. Rashid,et al.  N‐docosahexaenoylethanolamine is a potent neurogenic factor for neural stem cell differentiation , 2013, Journal of neurochemistry.

[167]  J. Palmblad,et al.  Omega-3 fatty acids enhance phagocytosis of Alzheimer's disease-related amyloid-β42 by human microglia and decrease inflammatory markers. , 2013, Journal of Alzheimer's disease : JAD.

[168]  G. Cole,et al.  Neuroprotective action of omega-3 polyunsaturated fatty acids against neurodegenerative diseases: evidence from animal studies. , 2007, Prostaglandins, leukotrienes, and essential fatty acids.

[169]  R. Bazinet,et al.  The emerging role of group VI calcium-independent phospholipase A2 in releasing docosahexaenoic acid from brain phospholipids Published, JLR Papers in Press, February 5, 2008. , 2008, Journal of Lipid Research.

[170]  D. Deretic,et al.  Syntaxin 3 and SNAP-25 pairing, regulated by omega-3 docosahexaenoic acid, controls the delivery of rhodopsin for the biogenesis of cilia-derived sensory organelles, the rod outer segments , 2009, Journal of Cell Science.

[171]  C. Luu,et al.  Mfsd2a Is a Transporter for the Essential ω-3 Fatty Acid Docosahexaenoic Acid (DHA) in Eye and Is Important for Photoreceptor Cell Development* , 2016, The Journal of Biological Chemistry.

[172]  P. Barberger-Gateau,et al.  Fish, docosahexaenoic acid and Alzheimer's disease. , 2009, Progress in lipid research.

[173]  H. Singer.  An Historical Perspective , 1995 .

[174]  S. Rapoport.  Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. , 2014, ACS chemical neuroscience.

[175]  R. Bazinet,et al.  Whole body synthesis rates of DHA from α-linolenic acid are greater than brain DHA accretion and uptake rates in adult rats[S] , 2013, Journal of Lipid Research.

[176]  S. Rapoport,et al.  Adolescent Behavior and Dopamine Availability Are Uniquely Sensitive to Dietary Omega-3 Fatty Acid Deficiency , 2014, Biological Psychiatry.

[177]  R. Bazinet,et al.  The emerging role of docosahexaenoic acid in neuroinflammation. , 2008, Current opinion in investigational drugs.

[178]  J. Martins.  EPA but Not DHA Appears To Be Responsible for the Efficacy of Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation in Depression: Evidence from a Meta-Analysis of Randomized Controlled Trials , 2009, Journal of the American College of Nutrition.

[179]  Dana Kilroy,et al.  Eicosapentaenoic acid confers neuroprotection in the amyloid-β challenged aged hippocampus , 2007, Neurobiology of Aging.

[180]  J. Axelrod,et al.  Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[181]  V. Parikh,et al.  Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. , 2003, Prostaglandins, leukotrienes, and essential fatty acids.

[182]  S. Aid,et al.  Cyclooxygenases-1 and -2 differentially modulate leukocyte recruitment into the inflamed brain , 2010, The Pharmacogenomics Journal.

[183]  S. Rapoport,et al.  n-3 Polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism , 2007, Molecular Psychiatry.

[184]  R. Bazinet,et al.  n-3 Polyunsaturated fatty acids in animal models with neuroinflammation. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[185]  Takao Shimizu,et al.  A novel lysophosphatidic acid acyltransferase enzyme (LPAAT4) with a possible role for incorporating docosahexaenoic acid into brain glycerophospholipids. , 2014, Biochemical and biophysical research communications.

[186]  Trevor A. Mori,et al.  Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation[S] , 2014, Journal of Lipid Research.

[187]  P. Watkins.  Very-long-chain Acyl-CoA Synthetases* , 2008, Journal of Biological Chemistry.

[188]  P. Tso,et al.  Abnormalities in the fatty acid composition of the postmortem orbitofrontal cortex of schizophrenic patients: Gender differences and partial normalization with antipsychotic medications , 2007, Schizophrenia Research.

[189]  M. Masoodi,et al.  Inhibiting Mitochondrial β-Oxidation Selectively Reduces Levels of Nonenzymatic Oxidative Polyunsaturated Fatty Acid Metabolites in the Brain , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[190]  M. O’Banion,et al.  Neuroinflammation and Memory: The Role of Prostaglandins , 2009, Molecular Neurobiology.

[191]  E. Murphy.  Brain fixation for analysis of brain lipid-mediators of signal transduction and brain eicosanoids requires head-focused microwave irradiation: an historical perspective. , 2010, Prostaglandins & other lipid mediators.

[192]  [The role of prostaglandins]. , 1975, La Nouvelle presse medicale.

[193]  N. Bazan,et al.  Docosahexaenoic acid and the aging brain. , 2008, The Journal of nutrition.

[194]  F. Calon,et al.  Reduction in DHA transport to the brain of mice expressing human APOE4 compared to APOE2 , 2014, Journal of neurochemistry.

[195]  O. Manzoni,et al.  Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions , 2011, Nature Neuroscience.

[196]  F. Bosetti,et al.  Unesterified docosahexaenoic acid is protective in neuroinflammation , 2013, Journal of neurochemistry.

[197]  R. Andridge,et al.  Omega-3 supplementation lowers inflammation and anxiety in medical students: A randomized controlled trial , 2011, Brain, Behavior, and Immunity.

[198]  T. Bisogno,et al.  Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice , 2011, Nutrition & metabolism.

[199]  C. Funk,et al.  Prostaglandins and leukotrienes: advances in eicosanoid biology. , 2001, Science.

[200]  G. Reiser,et al.  Role of Ca2+-independent phospholipase A2 and n−3 polyunsaturated fatty acid docosahexaenoic acid in prostanoid production in brain: perspectives for protection in neuroinflammation , 2004, International Journal of Developmental Neuroscience.

[201]  G. D. Paolo,et al.  Linking lipids to Alzheimer's disease: cholesterol and beyond , 2011, Nature Reviews Neuroscience.

[202]  Peter Loppnau,et al.  Structure of LIMP-2 provides functional insights with implications for SR-BI and CD36 , 2013, Nature.

[203]  L. Rossetti,et al.  Hypothalamic sensing of fatty acids , 2005, Nature Neuroscience.

[204]  N. Salem,et al.  An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n‐6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance , 2005, Journal of neurochemistry.

[205]  J. Hamilton,et al.  CD36 enhances fatty acid uptake by increasing the rate of intracellular esterification but not transport across the plasma membrane. , 2013, Biochemistry.

[206]  S. Layé,et al.  Nutritional n-3 polyunsaturated fatty acids deficiency alters cannabinoid receptor signaling pathway in the brain and associated anxiety-like behavior in mice , 2012, Journal of Physiology and Biochemistry.

[207]  F. Pifferi,et al.  (n-3) polyunsaturated fatty acid deficiency reduces the expression of both isoforms of the brain glucose transporter GLUT1 in rats. , 2005, The Journal of nutrition.

[208]  P. Wong,et al.  Mfsd2a is a transporter for the essential omega-3 fatty acid docosahexaenoic acid , 2014, Nature.

[209]  Hee-Yong Kim,et al.  Synaptamide, endocannabinoid-like derivative of docosahexaenoic acid with cannabinoid-independent function. , 2013, Prostaglandins, leukotrienes, and essential fatty acids.

[210]  S. Carlson,et al.  Decreased brain docosahexaenoic acid content produces neurobiological effects associated with depression: Interactions with reproductive status in female rats , 2008, Psychoneuroendocrinology.

[211]  N. Bazan,et al.  The omega‐3 fatty acid–derived neuroprotectin D1 limits hippocampal hyperexcitability and seizure susceptibility in kindling epileptogenesis , 2011, Epilepsia.

[212]  K. Su,et al.  A meta-analytic review of double-blind, placebo-controlled trials of antidepressant efficacy of omega-3 fatty acids. , 2007, The Journal of clinical psychiatry.

[213]  Deepak L. Bhatt,et al.  Rimonabant for prevention of cardiovascular events (CRESCENDO): a randomised, multicentre, placebo-controlled trial , 2010, The Lancet.

[214]  S. Rapoport,et al.  Dietary n-3 PUFA deprivation alters expression of enzymes of the arachidonic and docosahexaenoic acid cascades in rat frontal cortex , 2007, Molecular Psychiatry.

[215]  Hee-Yong Kim,et al.  A synaptogenic amide N-docosahexaenoylethanolamide promotes hippocampal development. , 2011, Prostaglandins & other lipid mediators.

[216]  Robert C. Wolpert,et al.  A Review of the , 1985 .

[217]  S. Rapoport,et al.  Disturbed choline plasmalogen and phospholipid fatty acid concentrations in Alzheimer's disease prefrontal cortex. , 2011, Journal of Alzheimer's disease : JAD.

[218]  G. Reiser,et al.  Why does Brain Metabolism not Favor Burning of Fatty Acids to Provide Energy? - Reflections on Disadvantages of the Use of Free Fatty Acids as Fuel for Brain , 2013, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[219]  M. Berger,et al.  Effects of fish oil on the neuro-endocrine responses to an endotoxin challenge in healthy volunteers. , 2007, Clinical nutrition.